These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35638529)

  • 41. Epigenetic regulation of Neuregulin 1 promotes breast cancer progression associated to hyperglycemia.
    Lee C; Kim M; Park C; Jo W; Seo JK; Kim S; Oh J; Kim CS; Ryu HS; Lee KH; Park J
    Nat Commun; 2023 Jan; 14(1):439. PubMed ID: 36707514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA-98 inhibits the proliferation, invasion, migration and promotes apoptosis of breast cancer cells by binding to HMGA2.
    Wang MJ; Zhang H; Li J; Zhao HD
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30049846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2.
    Liu M; Gou L; Xia J; Wan Q; Jiang Y; Sun S; Tang M; He T; Zhang Y
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29941860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuregulin-1 promotes the proliferation, migration, and angiogenesis of human periodontal ligament stem cells in vitro.
    Li L; Shang L; Kang W; Du L; Ge S
    Cell Biol Int; 2022 May; 46(5):792-805. PubMed ID: 35077607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LH-induced neuregulin 1 (NRG1) type III transcripts control granulosa cell differentiation and oocyte maturation.
    Noma N; Kawashima I; Fan HY; Fujita Y; Kawai T; Tomoda Y; Mihara T; Richards JS; Shimada M
    Mol Endocrinol; 2011 Jan; 25(1):104-16. PubMed ID: 21047912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasonic irradiation and SonoVue microbubbles-mediated RNA interference targeting PRR11 inhibits breast cancer cells proliferation and metastasis, but promotes apoptosis.
    Luo H; Li J; Lin Q; Xiao X; Shi Y; Ye X; Wei Z; Liu Y; Xu J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33057583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.
    Huang HE; Chin SF; Ginestier C; Bardou VJ; Adélaïde J; Iyer NG; Garcia MJ; Pole JC; Callagy GM; Hewitt SM; Gullick WJ; Jacquemier J; Caldas C; Chaffanet M; Birnbaum D; Edwards PA
    Cancer Res; 2004 Oct; 64(19):6840-4. PubMed ID: 15466169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Angiogenesis by Using CD105 and CD34 in Sudanese Breast Cancer Patients.
    M Abbas A; Shalabi MG; A Elsiddig S; Eltahir Z; M A Babker A; G Ahmed H
    Pak J Biol Sci; 2021 Jan; 24(11):1144-1151. PubMed ID: 34842386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer.
    Zhang TT; Qu N; Sun GH; Zhang L; Wang YJ; Mu XM; Wei WJ; Wang YL; Wang Y; Ji QH; Zhu YX; Shi RL
    Int J Oncol; 2018 Aug; 53(2):685-693. PubMed ID: 29901070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monensin inhibits proliferation, migration, and promotes apoptosis of breast cancer cells via downregulating UBA2.
    Gu J; Huang L; Zhang Y
    Drug Dev Res; 2020 Sep; 81(6):745-753. PubMed ID: 32462716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3.
    Le Clorennec C; Bazin H; Dubreuil O; Larbouret C; Ogier C; Lazrek Y; Garambois V; Poul MA; Mondon P; Barret JM; Mathis G; Prost JF; Pèlegrin A; Chardès T
    Mol Cancer Ther; 2017 Jul; 16(7):1312-1323. PubMed ID: 28507002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulation of MIIP regulates human breast cancer proliferation, invasion and migration by mediated by IGFBP2.
    Du Y; Wang P
    Pathol Res Pract; 2019 Jul; 215(7):152440. PubMed ID: 31078343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
    Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
    Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Schizophrenia-relevant behaviours of female mice overexpressing neuregulin 1 type III.
    Olaya JC; Heusner CL; Matsumoto M; Shannon Weickert C; Karl T
    Behav Brain Res; 2018 Nov; 353():227-235. PubMed ID: 29559337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of NRG1 promotes progression of gastric cancer by regulating the self-renewal of cancer stem cells.
    Han ME; Kim HJ; Shin DH; Hwang SH; Kang CD; Oh SO
    J Gastroenterol; 2015 Jun; 50(6):645-56. PubMed ID: 25381017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.
    Wang LB; Feng L; He J; Liu B; Sun JG
    Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596
    [No Abstract]   [Full Text] [Related]  

  • 57. Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.
    Xing Z; Zhang M; Wang X; Liu J; Liu G; Feng K; Wang X
    J Mol Histol; 2021 Aug; 52(4):809-821. PubMed ID: 34009515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis.
    Nagasaka M; Ou SI
    Trends Cancer; 2022 Mar; 8(3):242-258. PubMed ID: 34996744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts.
    Berdiel-Acer M; Maia A; Hristova Z; Borgoni S; Vetter M; Burmester S; Becki C; Michels B; Abnaof K; Binenbaum I; Bethmann D; Chatziioannou A; Hasmann M; Thomssen C; Espinet E; Wiemann S
    Oncogene; 2021 Apr; 40(15):2651-2666. PubMed ID: 33692466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.
    Newell KA; Karl T; Huang XF
    Neuroscience; 2013 Sep; 248():670-80. PubMed ID: 23811072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.